BRCA1/2 testing in hereditary breast and ovarian cancer families II: Impact on relationships

被引:28
|
作者
McInerney-Leo, A
Biesecker, BB
Hadley, DW
Kase, RG
Giambarresi, TR
Johnson, E
Lerman, C
Struewing, JP
机构
[1] NHGRI, Med Genet Branch, Bethesda, MD 20892 USA
[2] NCI, Genet Epidemiol Branch, Bethesda, MD 20892 USA
[3] Westat Res, Rockville, MD USA
[4] Johns Hopkins Biostat Ctr, Baltimore, MD USA
[5] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA
[6] NCI, Lab Populat Genet, Bethesda, MD 20892 USA
关键词
family cohesion; conflict; expressiveness; genetic counseling; cancer risk testing;
D O I
10.1002/ajmg.a.30566
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Members of hereditary breast and ovarian cancer (HBOC) families often express concern during genetic counseling about the impact of BRCA1/2 testing on close relatives. Yet whether there are likely to be adverse effects of either the decision to undergo genetic testing or the results of testing on family relationships is unknown. One purpose of this study was to assess the impact on close family relationships. Within a randomized trial of breast cancer genetic counseling methods, members of 13 HBOC families were offered BRCA1/2 testing for a known family mutation. The Family Relationship Index (FRI) of the Family Environment Scale (FES) was used to measure perceived family cohesion, conflict, and expressiveness at baseline and again 6-9 months following the receipt of test results, or at the equivalent time for those who declined testing. Participants (n = 212) completed baseline and follow-up questionnaires. Comparisons were made between testers and non-testers as well as between those who tested positive and negative for the family mutation. One hundred eighty-one participants elected to undergo genetic testing (85%) and 47 (26%) were identified to have a mutation. After adjusting for baseline family relationship scores, counseling intervention, gender and marital status, non-testers reported a greater increase in expressiveness (P = 0.006) and cohesion (P = 0.04) than testers. Individuals who tested positive reported a decrease in expressiveness (P = 0.07), although as a trend. Regardless of test decision or test result, those who were randomized to a client-centered counseling intervention reported a decrease in conflict (P = 0.006). Overall, study results suggest that undergoing genetic testing and learning ones BRCA1/2 status may affect family relationships. Those individuals who declined testing reported feeling closer to family members and more encouraged to express emotions to other family members demonstrating potential benefit from the offer of testing. Since those who tested positive reported feeling less encouraged to express their emotions within the family, we recommend helping clients to identify others with whom they feel comfortable sharing their thoughts and feelings about their positive gene status and increased cancer risk. Published 2005 Wiley-Liss, Inc.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 50 条
  • [21] TESTING FOR BRCA1 IN HEREDITARY BREAST-CANCER
    VANCE, GH
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (11): : 845 - 846
  • [22] Outcome of BRCA1 and BRCA2 testing in 89 Dutch breast/ovarian cancer families.
    Gille, JJP
    Strunk, MHP
    van Schooten, RJ
    Zweemer, RP
    Verheijen, RHM
    Menko, FH
    Pals, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A66 - A66
  • [23] Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
    Petrucelli, Nancie
    Daly, Mary B.
    Feldman, Gerald L.
    GENETICS IN MEDICINE, 2010, 12 (05) : 245 - 259
  • [24] Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families
    de Bock, G.
    van der Kolk, D.
    Schaapveld, M.
    Jansen, L.
    Mourits, M. J.
    Oosterwijk, J. C.
    EJC SUPPLEMENTS, 2010, 8 (03): : 224 - 224
  • [25] BRCA1 testing in families with hereditary breast-ovarian cancer - A prospective study of patient decision making and outcomes
    Lerman, C
    Narod, S
    Schulman, K
    Hughes, C
    GomezCaminero, A
    Bonney, G
    Gold, K
    Trock, B
    Main, D
    Lynch, J
    Fulmore, C
    Snyder, C
    Lemon, SJ
    Conway, T
    Tonin, P
    Lenoir, G
    Lynch, H
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (24): : 1885 - 1892
  • [26] Spectrum of mutations in BRCA1 gene in hereditary forms of breast and ovarian cancer in Russian families
    Loginova, AN
    Pospekhova, NI
    Lyubchenko, LN
    Budilov, AV
    Zakhar'ev, VM
    Gar'kavtseva, RF
    Ginter, EK
    Karpukhin, AV
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 136 (03) : 276 - 278
  • [27] 'Indirect' BRCA1/2 testing. A useful approach in hereditary breast and ovarian cancer families without a living affected relative
    Cruger, DG
    Kruse, TA
    Gerdes, AM
    CLINICAL GENETICS, 2005, 68 (03) : 228 - 233
  • [28] Spectrum of Mutations in BRCA1 Gene in Hereditary Forms of Breast and Ovarian Cancer in Russian Families
    A. N. Loginova
    N. I. Pospekhova
    L. N. Lyubchenko
    A. V. Budilov
    V. M. Zakhar'ev
    R. F. Gar'kavtseva
    E. K. Ginter
    A. V. Karpukhin
    Bulletin of Experimental Biology and Medicine, 2003, 136 : 276 - 278
  • [29] Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)
    Blay, Pilar
    Santamaria, Inigo
    Pitiot, Ana S.
    Luque, Maria
    Alvarado, Marta G.
    Lastra, Ana
    Fernandez, Yolanda
    Paredes, Angeles
    Freije, Jose M. P.
    Balbin, Milagros
    BMC CANCER, 2013, 13
  • [30] Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)
    Pilar Blay
    Iñigo Santamaría
    Ana S Pitiot
    María Luque
    Marta G Alvarado
    Ana Lastra
    Yolanda Fernández
    Ángeles Paredes
    José MP Freije
    Milagros Balbín
    BMC Cancer, 13